David Ridley PhD

David Ridley is the Faculty Director for Health Sector Management at Duke University’s Fuqua School of Business. He studies pharmaceutical innovation, manufacturing, and prices. He is especially interested in how to encourage development of drugs and vaccines for neglected diseases. David was the lead author of the paper proposing the priority review voucher program which became law and created a market of more than a billion dollars for drug development for neglected diseases. His research has been funded by the Bill & Melinda Gates Foundation and the National Institutes of Health. David teaches courses on health care policy and strategy to Duke University graduate students. He received a doctorate in economics from Duke University.

Drake C, McPeek Hinz E, Granger BB, Granados I, Rader A, Pitcher A, et al. Implementation of NCCARE360, a Digital Statewide Closed-Loop Referral Platform to Improve Health and Social Care Coordination: Evidence from the North Carolina COVID-19 Support Services Program. North Carolina medical journal. 2024 Mar;85(2):134–42.

Drake C, Rader A, Clipper C, Haney M, Bulgin D, Cameron B, et al. Adaptation to Telehealth of Personalized Group Visits for Late Stage Diabetic Kidney Disease. Kidney360. 2023 Dec 1;4(12):1708–16.

Wang SM, Hogg HDJ, Sangvai D, Patel MR, Weissler EH, Kellogg KC, et al. Development and Integration of Machine Learning Algorithm to Identify Peripheral Arterial Disease: Multistakeholder Qualitative Study. JMIR Form Res. 2023 Sep 21;7:e43963.